Filing Details
- Accession Number:
- 0001821825-24-000002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-23 11:46:59
- Reporting Period:
- 2024-02-22
- Accepted Time:
- 2024-02-23 11:46:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1821825 | Organon & Co. | OGN | Pharmaceutical Preparations (2834) | 464838035 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1959622 | Kirke Weaver | C/O Organon &Amp; Co. 30 Hudson Street, Floor 33 Jersey City NJ 07302 | Gen. Counsel & Corp. Secy. | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-02-22 | 2,720 | $18.36 | 15,181 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
